L'infection au virus du papillome humain (VPH) - Institut national de ...

L’infection au virus du papillome humain (VPH)
SELLORS, J. W. « Cervical cancer prevention for all Canadians », Canadian Family Physician, vol.
45, février 1999, p. 245-247
SELLORS, J. W., et autres. « Prevalence and predictors of human papillomavirus infection in women
in Ontario, Canada », Canadian Medical Association Journal, vol. 163, n° 5, septembre 2000, p. 503-
508
SELLORS, J. W., et autres. « Comparison of self-collected vaginal, vulvar and urine samples with
physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous
intraepithelial lesions », Canadian Medical Association Journal, vol. 163, n° 5, septembre 2000, p.
513-518.
SHAH, K. V. et autres. « Antibodies to human papillomavirus 16 and subsequent in situ or invasive
cancer of the cervix », Cancer Epidemiology, Biomarkers and Prevention, vol. 6, n° 4, avril 1997, p.
233-237.
SHAW, P. A. « The history of cervical screening. I : The Pap test », Journal SOGC, février 2000, p.
110-114.
SHEETS, E. E. « Management of adenocarcinoma in situ, micro-invasive, and early stage
adenocarcinoma of the cervix », Current Opinion in Obstetrics and Gynecology, vol. 14, n° 1, février
2002, p. 53-57.
SHEPHERD, J., et autres. « Cervical cancer and sexual lifestyle : A systematic review of health
education interventions targeted at women », Health Education Research, vol. 15, n° 6, décembre
2000, p. 681-694.
SHEPHERD, J., et autres. « Interventions for encouraging sexual lifestyles and behaviours intended to
prevent cervical cancer », The Cochrane Database of Systematic Reviews, vol. 2001, n° 3, 2001,
CD001035.
SHERMAN, M. E., et autres. « Toward objective quality assurance in cervical cytopathology.
Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types »,
American Journal of Clinical Pathology, vol. 102, n° 2, 1994, p. 182-187.
SHERMAN, M. E., M. SCHIFFMAN, et J. T. COX. « Effects of age and human papilloma viral load
on colposcopy triage : Data from the randomised atypical squamous cells of undetermined
significance/low-grade squamous intraepithelial lesion triage study (ALTS) », Journal of the National
Cancer Institute, vol. 94, n° 2, janvier 2002, p. 102-107.
SHLAY, J. C., et autres. « Prediction of cervical intraepithelial neoplasia grade 2-3 using risk
assessment and human papillomavirus testing in women with atypia on Papanicolaou smears »,
Obstetrics and Gynecology, vol. 96, n° 3, septembre 2000, p. 410-416.
SIGURDSSON, K. « Cervical cancer, Pap smear and HPV testing: An update of the role of organised
Pap smear screening and HPV testing » Acta Obstetricia et Gynecologica Scandinavica, vol. 78, 1999,
p. 467-477.
SILINS, I., et autres. « Serological evidence for protection by human papillomavirus (HPV) type 6
infection against HPV type 16 cervical carcinogenesis », Journal of General Virology, vol. 80, 1999,
p. 2931-2936.
Institut national de santé publique du Québec 153